Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants. (Renoir)
Sponsor: Nutricia Research
Listed as NCT03315221, this PHASE2/PHASE3 trial focuses on Growth and Safety and remains completed. Sponsored by Nutricia Research, it has been updated 11 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Oct 2024 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
Status: Unknown → Completed
-
Sep 2024 — Oct 2024 [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
Status: Active Not Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Jan 2022 — Jan 2024 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jan 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Apr 2020 — Jun 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Jul 2018 — Apr 2020 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Nov 2017 — Jul 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Nutricia Research
For direct contact, visit the study record on ClinicalTrials.gov .